ALSO NOTED: Schering-Plough licenses acadesine; Alchemia raises $15M; DOR action date extended; andmuch more...

> Schering-Plough has licensed acadesine, an adenosine regulating agent, from PeriCor Therapeutics. No terms were released. Release

> Australia's Alchemia announced a $15.2 million placement. Release

> DOR BioPharma announced that the action date for the FDA's review of its NDA for orBec for the treatment of gastrointestinal graft-versus-host disease has been extended to October 21, 2007. Release

> Par Pharmaceutical has settled a patent despite with Ortho-McNeil Pharmaceutical. Release

And Finally... A collaboration between the Scripps Research Institute and IBM to find new antidotes to flu before new mutations surface is making some initial progress. Report